CN1436841A - 从虫草体分离培养的细棒束孢sx-1及其分离培养方法和用途 - Google Patents
从虫草体分离培养的细棒束孢sx-1及其分离培养方法和用途 Download PDFInfo
- Publication number
- CN1436841A CN1436841A CN 02103669 CN02103669A CN1436841A CN 1436841 A CN1436841 A CN 1436841A CN 02103669 CN02103669 CN 02103669 CN 02103669 A CN02103669 A CN 02103669A CN 1436841 A CN1436841 A CN 1436841A
- Authority
- CN
- China
- Prior art keywords
- culture
- parts
- rod bundle
- separation
- cordycep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000190633 Cordyceps Species 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 15
- 230000000877 morphologic effect Effects 0.000 claims abstract description 4
- 230000001580 bacterial effect Effects 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 229930006000 Sucrose Natural products 0.000 claims description 19
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 19
- 239000005720 sucrose Substances 0.000 claims description 19
- 239000002609 medium Substances 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 16
- 239000001888 Peptone Substances 0.000 claims description 14
- 108010080698 Peptones Proteins 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 14
- 235000019319 peptone Nutrition 0.000 claims description 14
- 239000012138 yeast extract Substances 0.000 claims description 14
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 12
- 229910019142 PO4 Inorganic materials 0.000 claims description 11
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 11
- 229910052700 potassium Inorganic materials 0.000 claims description 11
- 239000011591 potassium Substances 0.000 claims description 11
- 229940041514 candida albicans extract Drugs 0.000 claims description 10
- 238000011081 inoculation Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 7
- 239000008272 agar Substances 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 230000003716 rejuvenation Effects 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 5
- 229940066779 peptones Drugs 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 102000014171 Milk Proteins Human genes 0.000 claims description 3
- 108010011756 Milk Proteins Proteins 0.000 claims description 3
- 230000004888 barrier function Effects 0.000 claims description 3
- 238000005452 bending Methods 0.000 claims description 3
- 235000021239 milk protein Nutrition 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 229940041181 antineoplastic drug Drugs 0.000 claims description 2
- 239000006916 nutrient agar Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 2
- 229940033663 thimerosal Drugs 0.000 claims description 2
- 239000012092 media component Substances 0.000 claims 1
- 241000233866 Fungi Species 0.000 abstract description 12
- 206010028980 Neoplasm Diseases 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 230000037396 body weight Effects 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 240000001307 Myosotis scorpioides Species 0.000 description 9
- 235000021317 phosphate Nutrition 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000012364 cultivation method Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 201000007270 liver cancer Diseases 0.000 description 4
- 208000014018 liver neoplasm Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241001248590 Isaria Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 150000003838 adenosines Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 241000330899 Hepialus Species 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02103669 CN1212387C (zh) | 2002-02-08 | 2002-02-08 | 从虫草体分离培养的细棒束孢sx-1及其培养方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02103669 CN1212387C (zh) | 2002-02-08 | 2002-02-08 | 从虫草体分离培养的细棒束孢sx-1及其培养方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1436841A true CN1436841A (zh) | 2003-08-20 |
CN1212387C CN1212387C (zh) | 2005-07-27 |
Family
ID=27627911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02103669 Expired - Fee Related CN1212387C (zh) | 2002-02-08 | 2002-02-08 | 从虫草体分离培养的细棒束孢sx-1及其培养方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1212387C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228471A (zh) * | 2011-06-27 | 2011-11-02 | 山西大学 | 一种猫棒束孢菌丝体的用途 |
CN102813669A (zh) * | 2012-08-18 | 2012-12-12 | 山西省肿瘤医院 | 猫棒束孢粗多糖作为制备抗肿瘤药物的应用 |
CN107118967A (zh) * | 2017-07-12 | 2017-09-01 | 西藏藏草宜生生物科技有限公司 | 蝙蝠蛾被毛孢菌丝体快速分离复壮技术 |
CN109266557A (zh) * | 2018-10-17 | 2019-01-25 | 上海市农业科学院 | 一类具有保健作用的细脚棒束孢虫草复合种菌种的获得方法 |
-
2002
- 2002-02-08 CN CN 02103669 patent/CN1212387C/zh not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228471A (zh) * | 2011-06-27 | 2011-11-02 | 山西大学 | 一种猫棒束孢菌丝体的用途 |
CN102228471B (zh) * | 2011-06-27 | 2012-10-17 | 山西大学 | 一种猫棒束孢菌丝体的用途 |
CN102813669A (zh) * | 2012-08-18 | 2012-12-12 | 山西省肿瘤医院 | 猫棒束孢粗多糖作为制备抗肿瘤药物的应用 |
CN107118967A (zh) * | 2017-07-12 | 2017-09-01 | 西藏藏草宜生生物科技有限公司 | 蝙蝠蛾被毛孢菌丝体快速分离复壮技术 |
CN109266557A (zh) * | 2018-10-17 | 2019-01-25 | 上海市农业科学院 | 一类具有保健作用的细脚棒束孢虫草复合种菌种的获得方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1212387C (zh) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070004022A1 (en) | Industrial fermenting production process of Hirsutella hepiali Chen & Shen of anamorphic fungi related to Chinese Cordyceps Sinensis | |
CN102242069B (zh) | 一种蝉拟青霉菌株及其应用 | |
CN1029382C (zh) | 北冬虫夏草菌人工栽培子实体的方法 | |
CN102612985A (zh) | 一种蛹虫草菌丝体的生产工艺 | |
CN1861782A (zh) | 富硒蛹虫草的人工培养方法及子实体的应用 | |
CN107475130B (zh) | 细柄棒束孢新菌种及其栽培方法和用途 | |
CN1167825A (zh) | 蛹虫草等虫草的人工培养方法 | |
CN111996129B (zh) | 蝉花新菌株及其在抗肿瘤及抑菌方面的用途 | |
CN1232632C (zh) | 蝉拟青霉新菌株apc-20及其人工培养发酵方法 | |
WO2017202293A1 (zh) | 一种蝉花的人工培养方法 | |
CN1283778C (zh) | N6-(2-羟乙基)腺苷在制备镇痛药物中的应用 | |
CN100420679C (zh) | 化合物、菌株、及应用该菌株生产该化合物的方法 | |
CN1095103A (zh) | 虫草菌丝发酵生产工艺 | |
CN110447457B (zh) | 一种血红密孔菌菌株及其人工栽培方法和用途 | |
KR100405990B1 (ko) | 유기게르마늄 함유 동충하초의 제조방법 | |
CN1212387C (zh) | 从虫草体分离培养的细棒束孢sx-1及其培养方法和用途 | |
KR20040047730A (ko) | 펠리누스 린테우스 균사체 배양용 배지 조성물 | |
CN114854604B (zh) | 一种肉灵芝、包含肉灵芝的高浓度口服液及其制备方法 | |
CN1215754A (zh) | 冬虫夏草发酵产物的制备方法及其应用 | |
CN101407767A (zh) | 一种通过发酵生产冬虫夏草的方法 | |
CN109880747A (zh) | 一种成分与天然冬虫夏草一致的中国被毛孢人工培养物的制备方法 | |
CN1109103C (zh) | 九州虫草菌的人工培养方法及其子实体的应用 | |
CN1827633A (zh) | 从蝉拟青霉培养物中提取n6-(2-羟乙基)腺苷的方法 | |
CN110972806A (zh) | 朱红硫磺菌菌株培育方法、人工栽培方法 | |
CN110172408A (zh) | 一株桃儿七的内生真菌及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: REN LIANSHENG Free format text: FORMER OWNER: HEBEI SHENXING SEA-BUCKTHORN INST. Effective date: 20051118 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20051118 Address after: 030000 No. 3 Worker Street, Taiyuan, Shanxi province (Shanxi Tumor Institute) Patentee after: Ren Liansheng Address before: Xinhua Road 050000 Hebei city of Shijiazhuang province No. 539 company Shenxing Patentee before: Shenxing Sea-buckthorn Inst., Hebei |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |